科微学术

微生物学通报

基于CiteSpace分析铜绿假单胞菌耐药性研究热点与趋势
作者:
基金项目:

国家自然科学基金(32070103, 31860012); 陕西省“特支计划”区域发展人才项目(陕组通字[2020] 44 号); 陕西省普通高等学校青年杰出人才支持计划(陕高教组[2018] 111 号); 陕西高校青年创新团队(2022); 陕西省大学生创新创业训练项目(S202210719127)


Research hotspots and trends of Pseudomonas aeruginosa drug resistance: a study based on CiteSpace
Author:
  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献 [35]
  • |
  • 相似文献 [20]
  • | | |
  • 文章评论
    摘要:

    【背景】铜绿假单胞菌(Pseudomonas aeruginosa)是临床引发感染的主要病原菌之一,对多种抗菌药物均有耐药性,临床治疗难度大,对该病原菌耐药性的研究一直备受关注。【目的】基于CiteSpace可视化功能,探究铜绿假单胞菌耐药性研究现状、热点与发展趋势。【方法】利用文献计量分析法,以2014–2021年中国知网(CNKI)、万方数据库(Wanfang)、Web of Science (WoS)共8 996篇铜绿假单胞菌耐药性的中英文文献为分析样本,运用Citespace软件对文献发文量、作者合作网络、国家和机构合作网络、文献共被引及期刊分析、关键词聚类、突现等方面进行分析,以探究该研究主题的研究热点及趋势。【结果】英文文献发文量增长速度高于中文文献;我国文献发文量仅次于美国、印度,在该领域科研成果贡献度较高,国际学术影响力较大;中英文文献中均对院内感染疾病和耐碳青霉烯类铜绿假单胞菌持高关注度。然而,中文文献较关注铜绿假单胞菌耐药性的临床防治问题,英文文献则较关注铜绿假单胞菌耐药性的基础研究。【结论】国内外铜绿假单胞菌耐药性研究对院内感染疾病及新型耐药菌的产生与防治关注度最高,暗示以上研究主题是该领域的研究热点与趋势。

    Abstract:

    [Background] Pseudomonas aeruginosa, one of the main pathogens causing clinical infections, is resistant to a variety of antimicrobial agents, which is difficult to be treated in clinical practice. Increasing attention has been attached to the research on the drug resistance of P. aeruginosa. [Objective] With the visualization function of CiteSpace, we explored the status, hotspots and trend of the research on the drug resistance of P. aeruginosa. [Methods] We performed a bibliometric analysis involving 8 996 articles about the drug resistance of P. aeruginosa, which were published in Web of Science, CNKI, and Wanfang Data from 2014 to 2021. CiteSpace was used to analyze the number of articles published, author cooperation network, cooperation network of affiliated countries and institutions, and literature co-citation. Furthermore, we used CiteSpace to perform journal analysis, keyword clustering, and burst detection, aiming to reveal the hotspots and trends of this research field. [Results] The growth rate of the articles published in English was higher than that in Chinese. China ranked second only to the United States and India in the number of articles, showing great contribution to research achievements in this field and strong academic influence. The articles published in both Chinese and English concerned nosocomial infections and carbapenem-resistant P. aeruginosa. The difference was that papers published in Chinese focused more on the clinical prevention and treatment of drug resistance of P. aeruginosa, while those published in English mainly involved the basic research of the drug resistance. [Conclusion] The research on drug resistance of P. aeruginosa at home and abroad pays the highest attention to the production and control of new drug-resistant bacteria and nosocomial infection, suggesting that the above research topic is the research hotspot and trend in this field.

    参考文献
    [1] Strateva T, Yordanov D. Pseudomonas aeruginosa: a phenomenon of bacterial resistance[J]. Journal of Medical Microbiology, 2009, 58(Pt 9): 1133-1148
    [2] 齐志丽, 段美丽, 李昂. 铜绿假单胞菌耐药机制研究现状[J]. 山东医药, 2014, 54(4): 83-86 Qi ZL, Duan ML, Li A. Research status of drug resistance mechanism of Pseudomonas aeruginosa[J]. Shandong Medical Journal, 2014, 54(4): 83-86(in Chinese)
    [3] 金帆, 高艳梅, 黄亚佳, 蒲璐, 夏霖. 铜绿假单胞菌感染治疗现状[J]. 集成技术, 2021, 10(4): 50-66 Jin F, Gao YM, Huang YJ, Pu L, Xia L. Current therapies for Pseudomonas aeruginosa infection[J]. Journal of Integration Technology, 2021, 10(4): 50-66(in Chinese)
    [4] 杨淼, 董永权, 胡玥. 基于CiteSpace的混合学习研究热点及趋势分析[J]. 中国医学教育技术, 2017, 31(6): 644-650 Yang M, Dong YQ, Hu Y. Analysis of research hotspots and trend of CiteSpace-based blended learning[J]. China Medical Education Technology, 2017, 31(6): 644-650(in Chinese)
    [5] 赵丹群. 基于CiteSpace的科学知识图谱绘制若干问题探讨[J]. 情报理论与实践, 2012, 35(10): 56-58 Zhao DQ. Probe into several problems relating to mapping knowledge domains based on CiteSpace[J]. Information Studies: Theory & Application, 2012, 35(10): 56-58(in Chinese)
    [6] Wang ST, Cheng JL, Niu YT, Li PX, Zhang XQ, Lin JS. Strategies for zinc uptake in Pseudomonas aeruginosa at the host-pathogen interface[J]. Frontiers in Microbiology, 2021, 12: 741873
    [7] 李莉, 张艳秋, 郑伟超, 武静茹, 罗时旋, 陈伟秋, 李桂秋. 重症监护病房常见非发酵菌分布及耐药性分析[J]. 微生物学杂志, 2011, 31(1): 99-101 Li L, Zhang YQ, Zheng WC, Wu JR, Luo SX, Chen WQ, Li GQ. Distribution and drug-resistance analysis of common non-fermenting bacteria in intensive care units[J]. Journal of Microbiology, 2011, 31(1): 99-101(in Chinese)
    [8] Anwar H, Costerton JW. Enhanced activity of combination of tobramycin and piperacillin for eradication of sessile biofilm cells of Pseudomonas aeruginosa[J]. Antimicrobial Agents and Chemotherapy, 1990, 34(9): 1666-1671
    [9] Werner E, Roe F, Bugnicourt A, Franklin MJ, Heydorn A, Molin S, Pitts B, Stewart PS. Stratified growth in Pseudomonas aeruginosa biofilms[J]. Applied and Environmental Microbiology, 2004, 70(10): 6188-6196
    [10] Jefferson KK, Goldmann DA, Pier GB. Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms[J]. Antimicrobial Agents and Chemotherapy, 2005, 49(6): 2467-2473
    [11] Roy R, Tiwari M, Donelli G, Tiwari V. Strategies for combating bacterial biofilms: a focus on anti-biofilm agents and their mechanisms of action[J]. Virulence, 2018, 9(1): 522-554
    [12] Li XZ, Plésiat P, Nikaido H. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria[J]. Clinical Microbiology Reviews, 2015, 28(2): 337-418
    [13] Li XZ, Nikaido H. Efflux-mediated drug resistance in bacteria: an update[J]. Drugs, 2009, 69(12): 1555-1623
    [14] Abavisani M, Goudarzi M, Ghalavand Z, Hajikhani B, Rad ZR, Rad ZR, Hashemi A. Evaluation of efflux pumps overexpression and β-lactamase genes among colistin resistant Pseudomonas aeruginosa[J]. Gene Reports, 2021, 24: 101301
    [15] Lee NY, Ko WC, Hsueh PR. Nanoparticles in the treatment of infections caused by multidrug-resistant organisms[J]. Frontiers in Pharmacology, 2019, 10: 1153
    [16] Slavin YN, Asnis J, Häfeli UO, Bach H. Metal nanoparticles: understanding the mechanisms behind antibacterial activity[J]. Journal of Nanobiotechnology, 2017, 15(1): 65
    [17] Qais FA, Shafiq A, Ahmad I, Husain FM, Khan RA, Hassan I. Green synthesis of silver nanoparticles using Carum copticum: assessment of its quorum sensing and biofilm inhibitory potential against Gram negative bacterial pathogens[J]. Microbial Pathogenesis, 2020, 144: 104172
    [18] Yang L, Liu Y, Wang N, Wang H, Wang K, Luo XL, Dai RX, Tao RJ, Wang HJ, Yang JW. Albumin-based LL37 peptide nanoparticles as a sustained release system against Pseudomonas aeruginosa lung infection[J]. ACS Biomaterials Science & Engineering, 2021, 7(5): 1817-1826
    [19] Centers for Disease Control. Antibiotic resistance threats in the United States[DB/OL]. https://stacks.cdc.gov/view/cdc/20705
    [20] Tran TB, Velkov T, Nation RL, Forrest A, Tsuji BT, Bergen PJ, Li J. Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?[J]. International Journal of Antimicrobial Agents, 2016, 48(6): 592-597
    [21] Wickremasinghe H, Yu HH, Azad MAK, Zhao JX, Bergen PJ, Velkov T, Zhou QT, Zhu Y, Li J. Clinically relevant concentrations of polymyxin B and meropenem synergistically kill multidrug-resistant Pseudomonas aeruginosa and minimize biofilm formation[J]. Antibiotics: Basel, Switzerland, 2021, 10(4): 405
    [22] 聂亚红, 田可港, 孙玉娟, 牟晓峰. 医院铜绿假单胞菌的临床特征及危险因素分析[J]. 中国抗生素杂志, 2021, 46(6): 611-615 Nie YH, Tian KG, Sun YJ, Mu XF. Analysis of clinical infection distribution and risk factors of Pseudomonas aeruginosa in hospital[J]. Chinese Journal of Antibiotics, 2021, 46(6): 611-615(in Chinese)
    [23] 胡付品, 郭燕, 朱德妹, 汪复, 蒋晓飞, 徐英春, 张小江, 张朝霞, 季萍, 谢轶, 等. 2016年中国CHINET细菌耐药性监测[J]. 中国感染与化疗杂志, 2017, 17(5): 481-491 Hu FP, Guo Y, Zhu DM, Wang F, Jiang XF, Xu YC, Zhang XJ, Zhang ZX, Ji P, Xie Y, et al. CHINET surveillance of bacterial resistance across China: report of the results in 2016[J]. Chinese Journal of Infection and Chemotherapy, 2017, 17(5): 481-491(in Chinese)
    [24] 胡付品, 郭燕, 朱德妹, 汪复, 蒋晓飞, 徐英春, 张小江, 张朝霞, 季萍, 谢轶, 等. 2017年CHINET中国细菌耐药性监测[J]. 中国感染与化疗杂志, 2018(3): 241-251 Hu FP, Guo Y, Zhu DM, Wang F, Jiang XF, Xu YC, Zhang XJ, Zhang Zx, Ji P, Xie Y, et al. Antimicrobial resistance profile of clinical isolates in hospitals across China: report from the CHINET Surveillance Program, 2017[J]. Chinese Journal of Infection and Chemotherapy, 2018(3): 241-251(in Chinese)
    [25] 胡付品, 郭燕, 朱德妹, 汪复, 蒋晓飞, 徐英春, 张小江, 张朝霞, 季萍, 谢轶, 等. 2018年CHINET中国细菌耐药性监测[J]. 中国感染与化疗杂志, 2020, 20(1): 1-10 Hu FP, Guo Y, Zhu DM, Wang F, Jiang XF, Xu YC, Zhang XJ, Zhang ZX, Ji P, Xie Y, et al. CHINET surveillance of bacterial resistance in China: 2018 report[J]. Chinese Journal of Infection and Chemotherapy, 2020, 20(1): 1-10(in Chinese)
    [26] 高洪锋, 程端, 雷静, 朱文明, 哈斯也提. 住院ICU呼吸机相关肺炎患者革兰阴性菌感染状况研究[J]. 中华医院感染学杂志, 2019, 29(7): 997-999 Gao HF, Cheng D, Lei J, Zhu WM, Ha S. Study on infection status of Gram-negative bacteria in inpatient ICU ventilator-associated pneumonia[J]. Chinese Journal of Nosocomiology, 2019, 29(7): 997-999(in Chinese)
    [27] 苏冬梅, 黄燕, 刘一, 刘颖, 张波. 铜绿假单胞菌血流感染多重耐药患者临床特征分析[J]. 解放军医学院学报, 2017, 38(2): 136-139 Su DM, Huang Y, Liu Y, Liu Y, Zhang B. Clinical characteristics of multidrug resistant Pseudomonas aeruginosa bloodstream infection[J]. Academic Journal of Chinese PLA Medical School, 2017, 38(2): 136-139(in Chinese)
    [28] 肖江琴, 张晓燕, 张秀敏. 新疆地区ICU护士长呼吸机相关性肺炎预防措施认知现状调查[J]. 海南医学, 2017, 28(19): 3247-3249 Xiao JQ, Zhang XY, Zhang XM. Investigation on cognition status of preventive measures of ventilator-associated pneumonia in ICU head nurses in Xinjiang[J]. Hainan Medical Journal, 2017, 28(19): 3247-3249(in Chinese)
    [29] 胡雪君. 老年铜绿假单胞菌血流感染诊治进展[J]. 实用老年医学, 2019, 33(3): 215-218 Hu XJ. Progress in diagnosis and treatment of Pseudomonas aeruginosa bloodstream infection in the elderly[J]. Practical Geriatrics, 2019, 33(3): 215-218(in Chinese)
    [30] 王缉义, 蒙光义, 周丽娟, 梁翠玲. 碳青霉烯类耐药铜绿假单胞菌感染治疗的研究进展[J]. 西北药学杂志, 2019, 34(3): 416-421 Wang JY, Meng GY, Zhou LJ, Liang CL. Progress in the treatment of carbapenem-resistant Pseudomonas aeruginosa infection[J]. Northwest Pharmaceutical Journal, 2019, 34(3): 416-421(in Chinese)
    [31] 马慧, 陈磊, 康薇, 王勇. 耐碳青霉烯类铜绿假单胞菌耐药机制及高危因素的研究进展[J]. 广东化工, 2021, 48(12): 110-111 Ma H, Chen L, Kang W, Wang Y. Research progress on resistance mechanism and high-risk factors of carbapenem-resistant Pseudomonas aeruginosa[J]. Guangdong Chemical Industry, 2021, 48(12): 110-111(in Chinese)
    [32] Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis[J]. The Lancet Infectious Diseases, 2018, 18(3): 318-327
    [33] 张明月, 胡福泉, 黄广涛. 铜绿假单胞菌必需基因的研究进展[J]. 微生物学通报, 2021, 48(6): 2143-2154 Zhang MY, Hu FQ, Huang GT. Progress of essential genes in Pseudomonas aeruginosa[J]. Microbiology China, 2021, 48(6): 2143-2154(in Chinese)
    [34] 谢朝云, 熊芸, 覃家露, 孙静. 耐碳青霉烯类铜绿假单胞菌的感染特征和危险因素分析[J]. 中国抗生素杂志, 2018, 43(7): 905-909 Xie CY, Xiong Y, Qin JL, Sun J. Analysis of infection characteristics and risk factors of carbapenem resistant Pseudomonas aeruginosa[J]. Chinese Journal of Antibiotics, 2018, 43(7): 905-909(in Chinese)
    [35] 彭召红, 曹贤, 曹青凤. 耐碳青霉烯类铜绿假单胞菌感染的危险因素及治疗的研究进展[J]. 国外医药: 抗生素分册, 2021, 42(2): 70-76 Peng ZH, Cao X, Cao QF. Research for the progress on risk factors and treatment of carbapenem resistant Pseudomonas aeruginosa infection[J]. World Notes on Antibiotics, 2021, 42(2): 70-76(in Chinese)
    引证文献
    网友评论
    网友评论
    分享到微博
    发 布
引用本文

宁婉清,杨建社,成娟丽,林金水. 基于CiteSpace分析铜绿假单胞菌耐药性研究热点与趋势[J]. 微生物学通报, 2022, 49(11): 4942-4956

复制
分享
文章指标
  • 点击次数:400
  • 下载次数: 1189
  • HTML阅读次数: 1029
  • 引用次数: 0
历史
  • 收稿日期:2022-04-05
  • 最后修改日期:2022-04-29
  • 录用日期:2022-04-29
  • 在线发布日期: 2022-11-07
  • 出版日期: 2022-11-20
文章二维码